MS & Stem Cell Laboratories, Burden Centre, Frenchay Hospital, Bristol, UK.
Regen Med. 2010 May;5(3):425-39. doi: 10.2217/rme.10.10.
The genetic myelin disorders are a range of diseases that manifest with severe neurological problems, often from infancy. It has been postulated for some time that stem cells might be an effective treatment for these disorders, primarily as agents to restore dysfunctional or lost myelin. Stem cells, however, may offer a wider range of therapeutic potential, for instance as vehicles to replace abnormal enzymes or genes, or to provide trophic support for residual CNS tissue. This article will review several of the more common genetic myelin disorders and currently available therapies, including bone marrow transplantation for adrenoleukodystrophy. Specific stem cell subtypes and their relevance to potential therapeutic use will be discussed and stem cell transplantation in animal model studies will also be reviewed.
遗传性髓鞘疾病是一系列表现为严重神经问题的疾病,通常在婴儿期发病。一段时间以来,人们一直假设干细胞可能是这些疾病的有效治疗方法,主要是作为恢复功能失调或丧失髓鞘的药物。然而,干细胞可能具有更广泛的治疗潜力,例如作为替代异常酶或基因的载体,或为中枢神经系统残留组织提供营养支持。本文将综述几种较为常见的遗传性髓鞘疾病和现有的治疗方法,包括骨髓移植治疗肾上腺脑白质营养不良。将讨论特定的干细胞亚型及其与潜在治疗用途的相关性,并综述动物模型研究中的干细胞移植。